Clinical Trials Browser

Phase 1 × B-Cell Malignancies × urelumab × Clear all

NCT01775631 2017-03-31

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

Phase 1 Completed

B-Cell Malignancies